Cargando…

Osteoclast and Sclerostin Expression in Osteocytes in the Femoral Head with Risedronate Therapy in Patients with Hip Fractures: A Retrospective Comparative Study

Background and Objectives: The majority of research on the effects of osteoporosis drugs has measured the bone mineral density (BMD) of the spine and femur through dual-energy X-ray absorptiometry (DEXA) and compared and analyzed the effects of the drugs through changes in the BMD values. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hwan-Hee, Choi, Eun-Yong, Jun, Hyun-Sik, Kim, Young-Yul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695260/ https://www.ncbi.nlm.nih.gov/pubmed/36363523 http://dx.doi.org/10.3390/medicina58111566

Ejemplares similares

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
por: Wijenayaka, Asiri R., et al.
Publicado: (2011)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
por: Laster, Marciana, et al.
Publicado: (2023)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
por: Jiang, Zengxin, et al.
Publicado: (2023)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
por: Liu, Wen, et al.
Publicado: (2019)

Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
por: Pacicca, Donna M., et al.
Publicado: (2019)

Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes
por: Qin, Lei, et al.
Publicado: (2021)

Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips
por: Zarei, Allahdad, et al.
Publicado: (2017)

Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020)

Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
por: Gates, Brian J., et al.
Publicado: (2012)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats
por: Ye, Tingjun, et al.
Publicado: (2017)

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018)

Effect of TNF-α-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement
por: Ohori, Fumitoshi, et al.
Publicado: (2019)

Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis
por: Kim, Ji-Hye, et al.
Publicado: (2017)

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women
por: Osaki, M., et al.
Publicado: (2011)

Fluorescent Risedronate Analogues Reveal Bisphosphonate Uptake by Bone Marrow Monocytes and Localization Around Osteocytes In Vivo
por: Roelofs, Anke J, et al.
Publicado: (2010)

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
por: van Bezooijen, Rutger L., et al.
Publicado: (2004)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

Osteocyte expression of caspase-3, COX-2, IL-6 and sclerostin are spatially and temporally associated following stress fracture initiation
por: Wu, Andy C, et al.
Publicado: (2014)

The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
por: Siegenthaler, Barbara, et al.
Publicado: (2018)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
por: Kratochvilova, Adela, et al.
Publicado: (2021)

Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
por: Cho, Yong Ho, et al.
Publicado: (2020)

A Review of the Potential Application of Osteocyte-Related Biomarkers, Fibroblast Growth Factor-23, Sclerostin, and Dickkopf-1 in Predicting Osteoporosis and Fractures
por: Ramli, Fitri Fareez, et al.
Publicado: (2020)

Oxidative Stress Induced Osteocyte Apoptosis in Steroid‐Induced Femoral Head Necrosis
por: Fan, Zhen‐Qi, et al.
Publicado: (2021)

Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
por: Kitaura, Hideki, et al.
Publicado: (2020)

Traumatic Hip Dislocation with Associated Femoral Head Fracture
por: Dortaj, H., et al.
Publicado: (2015)

Femoral Head Fracture Without Associated Hip Dislocation
por: Shaikh, Ashraf, et al.
Publicado: (2021)

Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: A systematic review and meta-analysis
por: Ren, Liang, et al.
Publicado: (2018)

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model
por: Eudy, RJ, et al.
Publicado: (2015)

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
por: Basha, Genc, et al.
Publicado: (2016)

Case of femoral diaphyseal stress fracture after long-term risedronate administration diagnosed by iliac bone biopsy
por: Nagai, Takashi, et al.
Publicado: (2013)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
por: Kim, Hyung Joon, et al.
Publicado: (2019)

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
por: Silverman, S. L., et al.
Publicado: (2006)

Effects of risedronate on fracture risk in postmenopausal women with osteopenia
por: Siris, E. S., et al.
Publicado: (2007)

Mechanical Loading Reduces Inflammation-Induced Human Osteocyte-to-Osteoclast Communication
por: Pathak, Janak L., et al.
Publicado: (2015)

Management of femoral head fracture by Ganz surgical dislocation of the hip
por: Hosny, Hossam, et al.
Publicado: (2022)

The Osteocyte as a Novel Key Player in Understanding Periodontitis Through its Expression of RANKL and Sclerostin: a Review
por: de Vries, Teun J., et al.
Publicado: (2019)

Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report
por: Alfahad, Anas, et al.
Publicado: (2012)

Mechanical properties of trabeculae and osteocyte morphology change significantly in different areas of the necrotic femoral head
por: He, Min-Cong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8oihrdiiv49t12g3o98jhro1v6